Transcriptomics reveals in vivo efficacy of PARP inhibitor combinatorial synergy with platinum-based chemotherapy in human non-small cell lung carcinoma models
Transcriptomics reveals in vivo efficacy of PARP inhibitor combinatorial synergy with platinum-based chemotherapy in human non-small cell lung carcinoma models |
https://doi.org/10.18632/oncotarget.28162
Lindsay R. Stolzenburg,
Barrett Ainsworth,
Bridget Riley-Gillis,
Tibor Pakozdi,
Areej Ammar,
Paul A. Ellis,
Julie L. Wilsbacher,
and Cyril Y. Ramathal
|
1-12 |
Unravelling the underpinnings of hyperprogression and immunotherapy: back to the bench
Unravelling the underpinnings of hyperprogression and immunotherapy: back to the bench |
https://doi.org/10.18632/oncotarget.28098
Vivek Subbiah,
and Razelle Kurzrock
|
13-15 |
Oxygen-independent, CDK4/CDK6-dependent degradation of hypoxia-inducible factor-1α takes cancers’ breath away
Oxygen-independent, CDK4/CDK6-dependent degradation of hypoxia-inducible factor-1α takes cancers’ breath away |
https://doi.org/10.18632/oncotarget.28166
Len Neckers
|
16-17 |
The “Immunoscore” in rectal cancer: could we search quality beyond quantity of life?
The “Immunoscore” in rectal cancer: could we search quality beyond quantity of life? |
https://doi.org/10.18632/oncotarget.28100
Amos Kirilovsky,
Carine El Sissy,
Guy Zeitoun,
Florence Marliot,
Nacilla Haicheur,
Christine Lagorce-Pagès,
Julien Taieb,
Mehdi Karoui,
Petra Custers,
Edina Dizdarevic,
Soledad Iseas,
Torben Frøstrup Hansen,
Lars Henrik Jensen,
Geerard Beets,
Jean Pierre Gérard,
Mireia Castillo-Martin,
Nuno Figueiredo,
Angelita Habr-Gama,
Rodrigo Perez,
Jérôme Galon,
and Franck Pagès
|
18-31 |
Induction of serine hydroxymethyltransferase 2 promotes tumorigenesis and metastasis in neuroblastoma
Induction of serine hydroxymethyltransferase 2 promotes tumorigenesis and metastasis in neuroblastoma |
https://doi.org/10.18632/oncotarget.28168
Rachael A. Clark,
Jingbo Qiao,
Jillian C. Jacobson,
and Dai H. Chung
|
32-45 |
The androgen receptor inhibits transcription of GPER1 by preventing Sp1 and Sp3 from binding to the promoters in prostate cancer cells
The androgen receptor inhibits transcription of GPER1 by preventing Sp1 and Sp3 from binding to the promoters in prostate cancer cells |
https://doi.org/10.18632/oncotarget.28169
Austin McDermott,
KyoungHyun Kim,
Susan Kasper,
Shuk-Mei Ho,
and Yuet-Kin Leung
|
46-60 |
Early detection of treatment futility in patients with metastatic colorectal cancer
Early detection of treatment futility in patients with metastatic colorectal cancer |
https://doi.org/10.18632/oncotarget.28165
Jodi I. Rattner,
Karen A. Kopciuk,
Hans J. Vogel,
Patricia A. Tang,
Jeremy D. Shapiro,
Dongsheng Tu,
Derek J. Jonker,
Lillian L. Siu,
Chris J. O’Callaghan,
and Oliver F. Bathe
|
61-72 |
Altered glycosylation of several metastasis-associated glycoproteins with terminal GalNAc defines the highly invasive cancer cell phenotype
Altered glycosylation of several metastasis-associated glycoproteins with terminal GalNAc defines the highly invasive cancer cell phenotype |
https://doi.org/10.18632/oncotarget.28167
Elham Khosrowabadi,
Tomasz Wenta,
Salla Keskitalo,
Aki Manninen,
and Sakari Kellokumpu
|
73-89 |
Are 50 years enough to prove the brilliant Dilman’s idea?
Are 50 years enough to prove the brilliant Dilman’s idea? |
https://doi.org/10.18632/oncotarget.28097
Vladimir N. Anisimov
|
90-91 |
GZ17-6.02 and palbociclib interact to kill ER+ breast cancer cells
GZ17-6.02 and palbociclib interact to kill ER+ breast cancer cells |
https://doi.org/10.18632/oncotarget.28177
Laurence Booth,
Cameron West,
Robert P. Moore,
Daniel Von Hoff,
and Paul Dent
|
92-104 |
Exploiting protein family and protein network data to identify novel drug targets for bladder cancer
Exploiting protein family and protein network data to identify novel drug targets for bladder cancer |
https://doi.org/10.18632/oncotarget.28175
Tolulope Tosin Adeyelu,
Aurelio A. Moya-Garcia,
and Christine Orengo
|
105-117 |
Correction: Prediction of survival prognosis of non-small cell lung cancer by APE1 through regulation of epithelial-mesenchymal transition
Correction: Prediction of survival prognosis of non-small cell lung cancer by APE1 through regulation of epithelial-mesenchymal transition |
https://doi.org/10.18632/oncotarget.28141
Xi Wei,
Qing Li,
Ying Li,
Wei Duan,
Chongbiao Huang,
Xiangqian Zheng,
Lei Sun,
Jingtao Luo,
Dong Wang,
Sheng Zhang,
Xiaojie Xin,
and Ming Gao
|
118-119 |
Redefining and expanding the sphere of influence of BRCA in breast and colorectal cancers and beyond
Redefining and expanding the sphere of influence of BRCA in breast and colorectal cancers and beyond |
https://doi.org/10.18632/oncotarget.28164
Emil Lou
|
120-121 |
Suppressive GLI2 fragment enhances liver metastasis in colorectal cancer
Suppressive GLI2 fragment enhances liver metastasis in colorectal cancer |
https://doi.org/10.18632/oncotarget.28170
Ruiko Ogata,
Shiori Mori,
Hitoshi Ohmori,
Shingo Kishi,
Rina Fujiwara-Tani,
Takamitsu Sasaki,
Yukiko Nishiguchi,
Chie Nakashima,
Kei Goto,
Isao Kawahara,
Yi Luo,
and Hiroki Kuniyasu
|
122-135 |
Chimeric chromosome landscapes of human somatic cell cultures show dependence on stress and regulation of genomic repeats by CGGBP1
Chimeric chromosome landscapes of human somatic cell cultures show dependence on stress and regulation of genomic repeats by CGGBP1 |
https://doi.org/10.18632/oncotarget.28174
Subhamoy Datta,
Manthan Patel,
Sukesh Kashyap,
Divyesh Patel,
and Umashankar Singh
|
136-155 |
Synthesis of a novel nanobioconjugate for targeted photodynamic therapy of colon cancer enhanced with cannabidiol
Synthesis of a novel nanobioconjugate for targeted photodynamic therapy of colon cancer enhanced with cannabidiol |
https://doi.org/10.18632/oncotarget.28171
Nkune Williams Nkune,
Cherie Ann Kruger,
and Heidi Abrahamse
|
156-172 |
Seventh BHD international symposium: recent scientific and clinical advancement
Seventh BHD international symposium: recent scientific and clinical advancement |
https://doi.org/10.18632/oncotarget.28176
Mark R. Woodford,
Avgi Andreou,
Masaya Baba,
Irma van de Beek,
Chiara Di Malta,
Iris Glykofridis,
Hannah Grimes,
Elizabeth P. Henske,
Othon Iliopoulos,
Masatoshi Kurihara,
Romain Lazor,
W. Marston Linehan,
Kenki Matsumoto,
Stefan J. Marciniak,
Yukiko Namba,
Arnim Pause,
Neil Rajan,
Anindita Ray,
Laura S. Schmidt,
Wei Shi,
Ortrud K. Steinlein,
Julia Thierauf,
Roberto Zoncu,
Anna Webb,
and Mehdi Mollapour
|
173-181 |
Correction: Musashi2 promotes the development and progression of pancreatic cancer by down-regulating Numb protein
Correction: Musashi2 promotes the development and progression of pancreatic cancer by down-regulating Numb protein |
https://doi.org/10.18632/oncotarget.28157
Weiwei Sheng,
Ming Dong,
Chuanping Chen,
Yang Li,
Qingfeng Liu,
and Qi Dong
|
182-182 |
Influence of nutrition on stage-stratified survival in gastric cancer patients with postoperative complications
Influence of nutrition on stage-stratified survival in gastric cancer patients with postoperative complications |
https://doi.org/10.18632/oncotarget.28179
Noriyuki Hirahara,
Takeshi Matsubara,
Shunsuke Kaji,
Yuki Uchida,
Ryoji Hyakudomi,
Tetsu Yamamoto,
Kiyoe Takai,
Yohei Sasaki,
Koki Kawakami,
and Yoshitsugu Tajima
|
183-197 |
Common cancer treatments targeting DNA double strand breaks affect long-term memory and relate to immediate early gene expression in a sex-dependent manner
Common cancer treatments targeting DNA double strand breaks affect long-term memory and relate to immediate early gene expression in a sex-dependent manner |
https://doi.org/10.18632/oncotarget.28180
Sydney Weber Boutros,
Destine Krenik,
Sarah Holden,
Vivek K. Unni,
and Jacob Raber
|
198-213 |
Plasma biomarkers reflecting high oxidative stress in the prediction of myocardial injury due to anthracycline chemotherapy and the effect of carvedilol: insights from the CECCY Trial
Plasma biomarkers reflecting high oxidative stress in the prediction of myocardial injury due to anthracycline chemotherapy and the effect of carvedilol: insights from the CECCY Trial |
https://doi.org/10.18632/oncotarget.28182
Mauro Rogério de Barros Wanderley Jr.,
Mônica Samuel Ávila,
Miguel Morita Fernandes-Silva,
Fátima das Dores Cruz,
Sara Michelly Gonçalves Brandão,
Vagner Oliveira Carvalho Rigaud,
Ludhmila Abrahão Hajjar,
Roberto Kalil Filho,
Edécio Cunha-Neto,
Edimar Alcides Bocchi,
and Silvia Moreira Ayub-Ferreira
|
214-223 |
Impact of the glutathione synthesis pathway on sulfasalazine-treated endometrial cancer
Impact of the glutathione synthesis pathway on sulfasalazine-treated endometrial cancer |
https://doi.org/10.18632/oncotarget.28185
Kanako Sendo,
Manabu Seino,
Tsuyoshi Ohta,
and Satoru Nagase
|
224-236 |
Exploring the synergistic effects of cabozantinib and a programmed cell death protein 1 inhibitor in metastatic renal cell carcinoma with machine learning
Exploring the synergistic effects of cabozantinib and a programmed cell death protein 1 inhibitor in metastatic renal cell carcinoma with machine learning |
https://doi.org/10.18632/oncotarget.28183
Ignacio Durán,
Daniel Castellano,
Javier Puente,
Lidia Martín-Couce,
Esther Bello,
Urbano Anido,
José Manuel Mas,
and Luis Costa
|
237-256 |
Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. study
Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. study |
https://doi.org/10.18632/oncotarget.28178
Connor Willis,
Hillevi Bauer,
Trang H. Au,
Jyothi Menon,
Sudhir Unni,
Dao Tran,
Zachary Rivers,
Wallace Akerley,
Matthew B. Schabath,
Firas Badin,
Ashley Sekhon,
Malini Patel,
Bing Xia,
Beth Gustafson,
John L. Villano,
John-Michael Thomas,
Solomon J. Lubinga,
Michael A. Cantrell,
Diana Brixner,
and David Stenehjem
|
257-270 |
Correction: The attenuated hepatocellular carcinoma-specific Listeria vaccine Lmdd-MPFG prevents tumor occurrence through immune regulation of dendritic cells
Correction: The attenuated hepatocellular carcinoma-specific Listeria vaccine Lmdd-MPFG prevents tumor occurrence through immune regulation of dendritic cells |
https://doi.org/10.18632/oncotarget.28154
Xin Wan,
Ci Cheng,
Zhe Lin,
Runqiu Jiang,
Wei Zhao,
Xin Yan,
Junwei Tang,
Kun Yao,
Beicheng Sun,
and Yun Chen
|
271-272 |
Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancers
Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancers |
https://doi.org/10.18632/oncotarget.28188
Ami N. Shah,
Ashwin Sunderraj,
Brian Finkelman,
Sharlene H. See,
Andrew A. Davis,
Lorenzo Gerratana,
Firas Wehbe,
Neelima Katam,
Deva Mahalingam,
William J. Gradishar,
Amir Behdad,
Luis Blanco,
and Massimo Cristofanilli
|
273-280 |
GZ17-6.02 and axitinib interact to kill renal carcinoma cells
GZ17-6.02 and axitinib interact to kill renal carcinoma cells |
https://doi.org/10.18632/oncotarget.28189
Laurence Booth,
Cameron West,
Robert P. Moore,
Daniel Von Hoff,
and Paul Dent
|
281-290 |
PACER lncRNA regulates COX-2 expression in lung cancer cells
PACER lncRNA regulates COX-2 expression in lung cancer cells |
https://doi.org/10.18632/oncotarget.28190
Samuel Z. Desind,
Joseph R. Iacona,
Christina Y. Yu,
Antonina Mitrofanova,
and Carol S. Lutz
|
291-306 |
Antitumor effect of isoquercetin on tissue vasohibin expression and colon cancer vasculature
Antitumor effect of isoquercetin on tissue vasohibin expression and colon cancer vasculature |
https://doi.org/10.18632/oncotarget.28181
Daniel de Castilho da Silva,
Guilherme Di Camillo Orfali,
Maycon Giovani Santana,
Jessica Kaoru Yamamoto Palma,
Isabella Ramos de Oliveira Assunção,
Isadora Moraes Marchesi,
Ana Yoshie Kitagawa Grizotto,
Natália Peres Martinez,
Simone Felliti,
José Aires Pereira,
and Denise Gonçalves Priolli
|
307-318 |
ABT199/venetoclax potentiates the cytotoxicity of alkylating agents and fludarabine in acute myeloid leukemia cells
ABT199/venetoclax potentiates the cytotoxicity of alkylating agents and fludarabine in acute myeloid leukemia cells |
https://doi.org/10.18632/oncotarget.28193
Benigno C. Valdez,
David Murray,
Bin Yuan,
Yago Nieto,
Uday Popat,
and Borje S. Andersson
|
319-330 |
Correction: 2’-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer
Correction: 2’-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer |
https://doi.org/10.18632/oncotarget.28199
Lokesh Dalasanur Nagaprashantha,
Jyotsana Singhal,
Hongzhi Li,
Charles Warden,
Xueli Liu,
David Horne,
Sanjay Awasthi,
Ravi Salgia,
and Sharad S. Singhal
|
331-331 |
Etoposide-induced DNA damage is increased in p53 mutants: identification of ATR and other genes that influence effects of p53 mutations on Top2-induced cytotoxicity
Etoposide-induced DNA damage is increased in p53 mutants: identification of ATR and other genes that influence effects of p53 mutations on Top2-induced cytotoxicity |
https://doi.org/10.18632/oncotarget.28195
Daniel Menendez,
Jay R. Anand,
Carri C. Murphy,
Whitney J. Bell,
Jiaqi Fu,
Nadia Slepushkina,
Eugen Buehler,
Scott E. Martin,
Madhu Lal-Nag,
John L. Nitiss,
and Michael A. Resnick
|
332-346 |
Telomere shortening accelerates tumor initiation in the L2-IL1B mouse model of Barrett esophagus and emerges as a possible biomarker
Telomere shortening accelerates tumor initiation in the L2-IL1B mouse model of Barrett esophagus and emerges as a possible biomarker |
https://doi.org/10.18632/oncotarget.28198
Vincenz Sahm,
Carlo Maurer,
Theresa Baumeister,
Akanksha Anand,
Julia Strangmann,
Roland M. Schmid,
Timothy C. Wang,
and Michael Quante
|
347-359 |
A comparison of 64Cu-labeled bi-terminally PEGylated A20FMDV2 peptides targeting integrin ανβ6
A comparison of 64Cu-labeled bi-terminally PEGylated A20FMDV2 peptides targeting integrin ανβ6 |
https://doi.org/10.18632/oncotarget.28197
Truc T. Huynh,
Sreeja Sreekumar,
Cedric Mpoy,
and Buck E. Rogers
|
360-372 |
NOTCH1 PEST domain variants are responsive to standard of care treatments despite distinct transformative properties in a breast cancer model
NOTCH1 PEST domain variants are responsive to standard of care treatments despite distinct transformative properties in a breast cancer model |
https://doi.org/10.18632/oncotarget.28200
Karen Cravero,
Morgan V. Pantone,
Dong Ho Shin,
Riley Bergman,
Rory Cochran,
David Chu,
Daniel J. Zabransky,
Swathi Karthikeyan,
Ian G. Waters,
Natasha Hunter,
D. Marc Rosen,
Kelly Kyker-Snowman,
W. Brian Dalton,
Berry Button,
Dan Shinn,
Hong Yuen Wong,
Joshua Donaldson,
Paula J. Hurley,
Sarah Croessmann,
and Ben Ho Park
|
373-386 |
Metanephric adenoma: molecular study and review of the literature
Metanephric adenoma: molecular study and review of the literature |
https://doi.org/10.18632/oncotarget.28192
Enrique Rodríguez-Zarco,
Jesús Machuca-Aguado,
Laura Macías-García,
Ana Vallejo-Benítez,
and Juan José Ríos-Martín
|
387-392 |
The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer
The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer |
https://doi.org/10.18632/oncotarget.28202
Alexander W. Pohlman,
Hita Moudgalya,
Lia Jordano,
Gabriela C. Lobato,
David Gerard,
Michael J. Liptay,
Christopher W. Seder,
and Jeffrey A. Borgia
|
393-407 |
The long winding road to the safer glucocorticoid receptor (GR) targeting therapies
The long winding road to the safer glucocorticoid receptor (GR) targeting therapies |
https://doi.org/10.18632/oncotarget.28191
Ekaterina A. Lesovaya,
Daria Chudakova,
Gleb Baida,
Ekaterina M. Zhidkova,
Kirill I. Kirsanov,
Marianna G. Yakubovskaya,
and Irina V. Budunova
|
408-424 |
Correction: IL-17A weakens the antitumor immunity by inhibiting apoptosis of MDSCs in Lewis lung carcinoma bearing mice
Correction: IL-17A weakens the antitumor immunity by inhibiting apoptosis of MDSCs in Lewis lung carcinoma bearing mice |
https://doi.org/10.18632/oncotarget.28052
Juan Wang,
Yue Zhang,
Kai Yin,
Peiqi Xu,
Jie Tian,
Jie Ma,
Xinyu Tian,
Yungang Wang,
Xinyi Tang,
Huaxi Xu,
and Shengjun Wang
|
425-425 |
A liquid fraction of extracellular matrix inhibits glioma cell viability in vitro and in vivo
A liquid fraction of extracellular matrix inhibits glioma cell viability in vitro and in vivo |
https://doi.org/10.18632/oncotarget.28203
Mark H. Murdock,
George S. Hussey,
Jordan T. Chang,
Ryan C. Hill,
David G. Nascari,
Aparna V. Rao,
Kirk C. Hansen,
Lesley M. Foley,
T. Kevin Hitchens,
Nduka M. Amankulor,
and Stephen F. Badylak
|
426-438 |
Impact of combining vitamin C with radiation therapy in human breast cancer: does it matter?
Impact of combining vitamin C with radiation therapy in human breast cancer: does it matter? |
https://doi.org/10.18632/oncotarget.28204
Somayeh Khazaei,
Linn Nilsson,
Gabriel Adrian,
Helga Tryggvadottir,
Elise Konradsson,
Signe Borgquist,
Karolin Isaksson,
Crister Ceberg,
and Helena Jernström
|
439-453 |
Defining the mechanisms underlying cyclin dependent kinase control of HIF-1α
Defining the mechanisms underlying cyclin dependent kinase control of HIF-1α |
https://doi.org/10.18632/oncotarget.28208
Noel A. Warfel
|
454-455 |
Adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA): pathological pathway adaptations
Adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA): pathological pathway adaptations |
https://doi.org/10.18632/oncotarget.28210
Antonio Marchetti,
Fiamma Buttitta,
and Emanuela D’Angelo
|
456-463 |
Sequencing of BRCA1/2-alterations using NGS-based technology: annotation as a challenge
Sequencing of BRCA1/2-alterations using NGS-based technology: annotation as a challenge |
https://doi.org/10.18632/oncotarget.28213
Silvana Ebner,
Ria Winkelmann,
Saskia Martin,
Jens Köllermann,
Peter J. Wild,
and Melanie Demes
|
464-475 |
An investigation on [5 fluorouracil and epigallocatechin-3-gallate] complex activity on HT-29 cell death and its stability in gastrointestinal fluid
An investigation on [5 fluorouracil and epigallocatechin-3-gallate] complex activity on HT-29 cell death and its stability in gastrointestinal fluid |
https://doi.org/10.18632/oncotarget.28207
Laura Moracci,
Francesca Sensi,
Andrea Biccari,
Sara Crotti,
Elisa Gaio,
Federico Benetti,
Pietro Traldi,
Salvatore Pucciarelli,
and Marco Agostini
|
476-489 |
Transplantation of autologous bone marrow pre-loaded ex vivo with oncolytic myxoma virus is efficacious against drug-resistant Vk*MYC mouse myeloma
Transplantation of autologous bone marrow pre-loaded ex vivo with oncolytic myxoma virus is efficacious against drug-resistant Vk*MYC mouse myeloma |
https://doi.org/10.18632/oncotarget.28205
Nancy Y. Villa,
Masmudur M. Rahman,
Joseph Mamola,
Meaghen E. Sharik,
Ana Lemos de Matos,
Jacquelyn Kilbourne,
Kenneth Lowe,
Juliane Daggett-Vondras,
Julia D'Isabella,
Elizabeth Goras,
Marta Chesi,
P. Leif Bergsagel,
and Grant McFadden
|
490-504 |
Correction: Human astrocytes secrete IL-6 to promote glioma migration and invasion through upregulation of cytomembrane MMP14
Correction: Human astrocytes secrete IL-6 to promote glioma migration and invasion through upregulation of cytomembrane MMP14 |
https://doi.org/10.18632/oncotarget.28211
Weiliang Chen,
Tongliang Xia,
Donghai Wang,
Bin Huang,
Peng Zhao,
Jian Wang,
Xun Qu,
and Xingang Li
|
505-506 |
Correction: Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer
Correction: Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer |
https://doi.org/10.18632/oncotarget.28206
Bing Guan,
Kaijie Wu,
Jin Zeng,
Shan Xu,
Lijun Mu,
Yang Gao,
Ke Wang,
Zhenkun Ma,
Juanhua Tian,
Qi Shi,
Peng Guo,
Xinyang Wang,
Dalin He,
and Yuefeng Du
|
507-507 |
Cytogenetic and molecular analyses of 291 gastrointestinal stromal tumors: site-specific cytogenetic evolution as evidence of pathogenetic heterogeneity
Cytogenetic and molecular analyses of 291 gastrointestinal stromal tumors: site-specific cytogenetic evolution as evidence of pathogenetic heterogeneity |
https://doi.org/10.18632/oncotarget.28209
Ludmila Gorunova,
Kjetil Boye,
Ioannis Panagopoulos,
Jeanne-Marie Berner,
Bodil Bjerkehagen,
Ivar Hompland,
Ingvild Lobmaier,
Toto Hølmebakk,
Tarjei S. Hveem,
Sverre Heim,
and Francesca Micci
|
508-517 |
Correction: Clinical significance and effect of AEG-1 on the proliferation, invasion, and migration of NSCLC: a study based on immunohistochemistry, TCGA, bioinformatics, in vitro and in vivo verification
Correction: Clinical significance and effect of AEG-1 on the proliferation, invasion, and migration of NSCLC: a study based on immunohistochemistry, TCGA, bioinformatics, in vitro and in vivo verification |
https://doi.org/10.18632/oncotarget.28212
Yu Zhang,
Zu-Yun Li,
Xin-Xi Hou,
Xiao Wang,
Yi-Huan Luo,
Yan-Ping Ying,
and Gang Chen
|
518-520 |
Correlation of nuclear pIGF-1R/IGF-1R and YAP/TAZ in a tissue microarray with outcomes in osteosarcoma patients
Correlation of nuclear pIGF-1R/IGF-1R and YAP/TAZ in a tissue microarray with outcomes in osteosarcoma patients |
https://doi.org/10.18632/oncotarget.28215
Eric R. Molina,
Letitia K. Chim,
Salah-Eddine Lamhamedi-Cherradi,
Sana Mohiuddin,
David McCall,
Branko Cuglievan,
Sandhya Krishnan,
Robert W. Porter,
Davis R. Ingram,
Wei-Lien Wang,
Alexander J. Lazar,
David W. Scott,
Danh D. Truong,
Najat C. Daw,
Joseph A. Ludwig,
and Antonios G. Mikos
|
521-533 |
MYH9 binds to dNTPs via deoxyribose moiety and plays an important role in DNA synthesis
MYH9 binds to dNTPs via deoxyribose moiety and plays an important role in DNA synthesis |
https://doi.org/10.18632/oncotarget.28219
Pratima Nangia-Makker,
Malathy P.V. Shekhar,
Victor Hogan,
Vitaly Balan,
and Avraham Raz
|
534-550 |
Retraction: Transcriptome analysis reveals a role for the endothelial ANP-GC-A signaling in interfering with pre-metastatic niche formation by solid cancers
Retraction: Transcriptome analysis reveals a role for the endothelial ANP-GC-A signaling in interfering with pre-metastatic niche formation by solid cancers |
https://doi.org/10.18632/oncotarget.28223
Takashi Nojiri,
Miki Arai,
Yutaka Suzuki,
Motofumi Kumazoe,
Takeshi Tokudome,
Koichi Miura,
Jun Hino,
Hiroshi Hosoda,
Mikiya Miyazato,
Meinoshin Okumura,
Shinpei Kawaoka,
and Kenji Kangawa
|
551-552 |
Patient-derived tumor models are attractive tools to repurpose drugs for ovarian cancer treatment: pre-clinical updates
Patient-derived tumor models are attractive tools to repurpose drugs for ovarian cancer treatment: pre-clinical updates |
https://doi.org/10.18632/oncotarget.28220
Magdalena Cybula,
and Magdalena Bieniasz
|
553-575 |
Resolution of radiation necrosis with bevacizumab following radiation therapy for primary CNS lymphoma
Resolution of radiation necrosis with bevacizumab following radiation therapy for primary CNS lymphoma |
https://doi.org/10.18632/oncotarget.28222
Eugene J. Vaios,
Kristen A. Batich,
Anne F. Buckley,
Anastasie Dunn-Pirio,
Mallika P. Patel,
John P. Kirkpatrick,
Ranjit Goudar,
and Katherine B. Peters
|
576-582 |
Correction: Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin
Correction: Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin |
https://doi.org/10.18632/oncotarget.28109
Sixian Liang,
Xun Peng,
Xiaoli Li,
Ping Yang,
Linhao Xie,
Yaochen Li,
Caiwen Du,
and Guojun Zhang
|
583-584 |
Correction: Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance
Correction: Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance |
https://doi.org/10.18632/oncotarget.28110
Benny Zhitomirsky,
and Yehuda G. Assaraf
|
585-586 |
Role of the prorenin receptor in endometrial cancer cell growth
Role of the prorenin receptor in endometrial cancer cell growth |
https://doi.org/10.18632/oncotarget.28224
Jacinta H. Martin,
Riazuddin Mohammed,
Sarah J. Delforce,
David A. Skerrett-Byrne,
Celine Corbisier de Meaultsart,
Juhura G. Almazi,
Andrew N. Stephens,
Nicole M. Verrills,
Evdokia Dimitriadis,
Yu Wang,
Eugenie R. Lumbers,
and Kirsty G. Pringle
|
587-599 |
A novel group of genes that cause endocrine resistance in breast cancer identified by dynamic gene expression analysis
A novel group of genes that cause endocrine resistance in breast cancer identified by dynamic gene expression analysis |
https://doi.org/10.18632/oncotarget.28225
Arvand Asghari,
Katherine Wall,
Michael Gill,
Natascha Del Vecchio,
Farnaz Allahbakhsh,
Jacky Wu,
Nan Deng,
W. Jim Zheng,
Hulin Wu,
Michihisa Umetani,
and Vahed Maroufy
|
600-613 |
Correction: MicroRNA-613 inhibits cell growth, migration and invasion of papillary thyroid carcinoma by regulating SphK2
Correction: MicroRNA-613 inhibits cell growth, migration and invasion of papillary thyroid carcinoma by regulating SphK2 |
https://doi.org/10.18632/oncotarget.28155
Wangwang Qiu,
Zhili Yang,
Youben Fan,
and Qi Zheng
|
614-614 |
Loss of DRO1/CCDC80 in the tumor microenvironment promotes carcinogenesis
Loss of DRO1/CCDC80 in the tumor microenvironment promotes carcinogenesis |
https://doi.org/10.18632/oncotarget.28084
Jessica I. Christian,
Agnieszka Pastula,
Andreas Herbst,
Jens Neumann,
Maximilian K. Marschall,
Andrea Ofner,
Heike Zierahn,
Marlon R. Schneider,
Eckhard Wolf,
Michael Quante,
and Frank T. Kolligs
|
615-627 |
Bladder cancer survival in patients with NOD2 or CDKN2A variants
Bladder cancer survival in patients with NOD2 or CDKN2A variants |
https://doi.org/10.18632/oncotarget.28226
Elżbieta Złowocka-Perłowska,
Thierry van de Wetering,
Aleksandra Tołoczko-Grabarek,
Rodney J. Scott,
and Jan Lubiński
|
628-640 |
Correction: MR imaging biomarkers evaluating vascular normalization window after anti-vessel treatment
Correction: MR imaging biomarkers evaluating vascular normalization window after anti-vessel treatment |
https://doi.org/10.18632/oncotarget.28217
Jun Yang,
Chengde Liao,
Yifan Liu,
Guangjun Yang,
Tengfei Ke,
Yingying Ding,
and Qinqing Li
|
641-641 |
Combined treatment with niclosamide and camptothecin enhances anticancer effect in U87 MG human glioblastoma cells
Combined treatment with niclosamide and camptothecin enhances anticancer effect in U87 MG human glioblastoma cells |
https://doi.org/10.18632/oncotarget.28227
Laura Valdez,
Benxu Cheng,
Daniela Gonzalez,
Reanna Rodriguez,
Paola Campano,
Andrew Tsin,
and Xiaoqian Fang
|
642-658 |
Proteomic analysis reveals dual requirement for Grb2 and PLCγ1 interactions for BCR-FGFR1-Driven 8p11 cell proliferation
Proteomic analysis reveals dual requirement for Grb2 and PLCγ1 interactions for BCR-FGFR1-Driven 8p11 cell proliferation |
https://doi.org/10.18632/oncotarget.28228
Malalage N. Peiris,
April N. Meyer,
Dalida Warda,
Alexandre Rosa Campos,
and Daniel J. Donoghue
|
659-676 |
Tazemetostat in relapsed/refractory follicular lymphoma: a propensity score–matched analysis of E7438-G000-101 trial outcomes
Tazemetostat in relapsed/refractory follicular lymphoma: a propensity score–matched analysis of E7438-G000-101 trial outcomes |
https://doi.org/10.18632/oncotarget.28229
David G. Proudman,
Deepshekhar Gupta,
Dave Nellesen,
Jay Yang,
Beth A. Kamp,
Khalid Mamlouk,
and Bruce D. Cheson
|
677-683 |
Correction: Silence of cancer susceptibility candidate 9 inhibits gastric cancer and reverses chemoresistance
Correction: Silence of cancer susceptibility candidate 9 inhibits gastric cancer and reverses chemoresistance |
https://doi.org/10.18632/oncotarget.27523
Chao Shang,
Lin Sun,
Jiale Zhang,
Bochao Zhao,
Xiuxiu Chen,
Huimian Xu,
and Baojun Huang
|
684-685 |
Response to immunotherapy in KRAS G12C mutated NSCLC: a single-centre retrospective observational study
Response to immunotherapy in KRAS G12C mutated NSCLC: a single-centre retrospective observational study |
https://doi.org/10.18632/oncotarget.28230
Carolina Sciortino,
Valentina Viglialoro,
Massimo Nucci,
Mariam Grazia Polito,
Enrico Cortesi,
Alain Gelibter,
Paola Gazzaniga,
Chiara Nicolazzo,
Marco Siringo,
and Salvatore Caponnetto
|
686-693 |